Protective effects of scutellarin on type II diabetes mellitus-induced testicular damages related to reactive oxygen species/Bcl-2/Bax and reactive oxygen species/microcirculation/staving pathway in diabetic rat

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Long, Lingli ^a   Wang, Jingnan ^a   Lu, Xiaofang ^a   Xu, Yuxia ^a   Zheng, Shuhui ^a   Luo, Canqiao ^a   Li, Yubin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; PROTECTIVE AGENT; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SCUTELLARIN; VASCULOTROPIN; APIGENIN; BAX PROTEIN, RAT; GLUCURONIC ACID; STREPTOZOCIN; VASCULOTROPIN A;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL; BLOOD VESSEL WALL; BODY WEIGHT; CELL STRUCTURE; CONTROLLED STUDY; DOPPLER FLOWMETRY; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDIDYMIS; GERM CELL; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LIPID DIET; MALE; MICROCIRCULATION; NICK END LABELING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEMINIFEROUS TUBULE; SPERMATOZOON; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TESTIS INJURY; TESTIS WEIGHT; WESTERN BLOTTING; ANIMAL; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; DOPPLER ULTRASONOGRAPHY; DRUG EFFECTS; GENE EXPRESSION REGULATION; HYPERGLYCEMIA; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TESTIS; TUNEL ASSAY; WISTAR RAT;

ANIMALS; APIGENIN; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOOD VESSELS; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUCURONATES; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MICROCIRCULATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STREPTOZOCIN; TESTIS; ULTRASONOGRAPHY, DOPPLER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84925625639     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/252530     Document Type: Article

References (49)

1. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, "Global prevalence of diabetes-estimates for the year 2000 and projections for 2030" Diabetes Care, vol. 27,no. 5, pp. 1047-1053, 2004.
2. L. Y.Melendez-Ramirez, R. J. Richards, andW. T. Cefalu, "Complications of type 1 diabetes" Endocrinology and Metabolism Clinics of North America, vol. 39, no. 3, pp. 625-640, 2010.
3. L. Cai, S. L. Chen, T. Evans, D. X. Deng, K. Mukherjee, and S. Chakrabarti, "Apoptotic germ-cell death and testicular damage in experimental diabetes: prevention by endothelin antagonism" Urological Research, vol. 28, no. 5, pp. 342-347, 2000.
4. G. C. Jain and R. N. Jangir, "Modulation of diabetes-mellitusinduced male reproductive dysfunctions in experimental animal models with medicinal plants" Pharmacognosy Reviews, vol. 8, no. 16, pp. 113-121, 2014.
5. Y. G. Zhao, Y. Tan, J. Y. Dai et al., "Exacerbation of diabetesinduced testicular apoptosis by zinc deficiency is most likely associated with oxidative stress, p38MAPK activation, and p53 activation in mice" Toxicology Letters, vol. 200, no. 1-2, pp. 100-106, 2011.
6. A. Ramond, D. Godin-Ribuot, C. Ribuot et al., "Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia" Fundamental and Clinical Pharmacology, vol. 27,no. 3, pp. 252-261, 2013.
7. M. D. Evans and M. S. Cooke, "Factors contributing to the outcome of oxidative damage to nucleic acids" BioEssays, vol. 26, no. 5, pp. 533-542, 2004.
8. B. Shrilatha, "Early oxidative stress in testis and epididymal sperm in streptozotocin-induced diabetic mice: its progression and genotoxic consequences" Reproductive Toxicology, vol. 23, no. 4, pp. 578-587, 2007.
9. B. Basha, S. M. Samuel,C.R.Triggle, andH. Ding, "Endothelial dysfunction in diabetesmellitus: possible involvement of endoplasmic reticulum stress? Experimental Diabetes Research, vol. 2012, Article ID481840, 14 pages, 2012.
10. F. Garcia Soriano, L. Viŕag, P. Jagtap et al., "Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation" Nature Medicine, vol. 7, no. 1, pp. 108-113, 2001.
11. M. E. Cooper, D. Vranes, S. Youssef et al., "Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes" Diabetes, vol. 48, no. 11, pp. 2229-2239, 1999.
12. B. Ruszkowska-Ciastek, A. Sokup, M. W. Socha et al., "A preliminary evaluation of VEGF-A, VEGFR1 and VEGFR2 in patients with well-controlled type 2 diabetes mellitus" Journal of Zhejiang University. Science B, vol. 15, no. 6, pp. 575-581, 2014.
13. S. M. Grundy, "Diabetes and coronary risk equivalency-what does it mean? Diabetes Care, vol. 29, no. 2, pp. 457-460, 2006.
14. U. Ketsawatsakul, M. Whiteman, and B. Halliwell, "A reevaluation of the peroxynitrite scavenging activity of some dietary phenolics" Biochemical and Biophysical Research Communications, vol. 279, no. 2, pp. 692-699, 2000.
15. S. Y. Tang,M.Whiteman, Z. F. Peng,A. Jenner, E. L. Yong, and B. Halliwell, "Characterization of antioxidant and antiglycation properties and isolation of active ingredients from traditional chinese medicines" Free Radical Biology and Medicine, vol. 36, no. 12, pp. 1575-1587, 2004.
16. B. Halliwell, "Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment" Drugs & Aging, vol. 18, no. 9, pp. 685-716, 2001.
17. V. Y. Waisundara, A. Hsu, D. Huang, and B. K.-H. Tan, "Scutellaria baicalensis: enhances the anti-diabetic activity of metformin in streptozotocin-induced diabeticWistar rats" The American Journal of Chinese Medicine, vol. 36, no. 3, pp. 517-540, 2008.
18. X.-X. Xu, W. Zhang, P. Zhang, X.-M. Qi, Y.-G. Wu, and J.-J. Shen, "Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats" Phytomedicine, vol. 20, no. 10, pp. 820-827, 2013.
19. M. Wang, W.-B. Zhang, J.-H. Zhu, G.-S. Fu, and B.-Q. Zhou, "Breviscapine ameliorates cardiac dysfunction and regulates the myocardial Ca2+-cycling proteins in streptozotocin-induced diabetic rats" Acta Diabetologica, vol. 47, no. 1, pp. S209-S218, 2010.
20. X. R. Li, L. J. Wang, Y. H. Li, L. Bai, and M. Xue, "Acute and subacute toxicological evaluation of scutellarin in rodents" Regulatory Toxicology and Pharmacology, vol. 60, no. 1, pp. 106-111, 2011.
21. J. A. Ross and C.M. Kasum, "Dietary flavonoids: bioavailability, metabolic effects, and safety" Annual Review of Nutrition, vol. 22, pp. 19-34, 2002.
22. Y. Su, W. Liu, L. Ma, X. Liu, Z. Liu, and B. Zhu, "Scutellarin inhibits translocation of protein kinase C in diabetic thoracic aorta of the rat" Clinical and Experimental Pharmacology and Physiology, vol. 39, no. 2, pp. 136-140, 2012.
23. A. R. Sisman, M. Kiray, U. M. Camsari et al., "Potential novel biomarkers for diabetic testicular damage in streptozotocininduced diabetic rats: nerve growth factor beta and vascular endothelial growth factor" Disease Markers, vol. 2014, Article ID 108106, 7 pages, 2014.
24. A. S. Driver, P. R. S. Kodavanti, and W. R. Mundy, "Age-related changes in reactive oxygen species production in rat brain homogenates" Neurotoxicology and Teratology, vol. 22,no. 2, pp. 175-181, 2000.
25. M. A. Pozor and S. M. McDonnell, "Color Doppler ultrasound evaluation of testicular blood flow in stallions"Theriogenology, vol. 61, no. 5, pp. 799-810, 2004.
26. G. Gaunay, H. M. Nagler, and D. S. Stember, "Reproductive sequelae of diabetes in male patients" Endocrinology andMetabolismClinics of North America, vol. 42, no. 4, pp. 899-914, 2013.
27. P. E. Jennersjo, M. Wijkman, A. B. Wirehn et al., "Circadian blood pressure variation in patients with type 2 diabetes-relationship between dipper status and early cardiovascular organ damage" Diabetologia, vol. 52, p. S430, 2009.
28. A. Adler, "Obesity and target organ damage: diabetes" International Journal of Obesity, vol. 26, no. 4, pp. S11-S14, 2002.
29. UK Prospective Diabetes Study Group, "Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38" British Medical Journal, vol. 317, p. 703, 1998.
30. K. Ikebukuro, Y. Adachi, Y. Yamada et al., "Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats" Transplantation, vol. 73, no. 4, pp. 512-518, 2002.
31. S. Amaral, A. J.Moreno, M. S. Santos, R. Seiça, and J. Ramalho-Santos, "Effects of hyperglycemia on sperm and testicular cells of Goto-Kakizaki and streptozotocin-treated rat models for diabetes"Theriogenology, vol. 66, no. 9, pp. 2056-2067, 2006.
32. S. Soudamani, S. Yuvaraj, T. Malini, and K. Balasubramanian, "Experimental diabetes has adverse effects on the differentiation of ventral prostate during sexual maturation of rats" The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, vol. 287, no. 2, pp. 1281-1289, 2005.
33. L. Navarro-Casado, M. A. Juncos-Tobarra, M. Chafer-Rudilla, L.I. de Onzõno, J. A. Bĺazquez-Cabrera, and J. M. Miralles-Garćia, "Effect of experimental diabetes and STZ on male fertility capacity. Study in rats" Journal of Andrology, vol. 31, no. 6, pp. 584-592, 2010.
34. H. Aybek, Z. Aybek, S. Rota, N. Şen, and M. Akbulut, "The effects of diabetes mellitus, age, and vitamin E on testicular oxidative stress" Fertility and Sterility, vol. 90, no. 3, pp. 755-760, 2008.
35. E.Kasahara, E. F. Sato,M.Miyoshi et al., "Roleofoxidative stress in germ cell apoptosis induced by di(2-ethylhexyl)phthalate" Biochemical Journal, vol. 365, no. 3, pp. 849-856, 2002.
36. R. J. Aitken and G. N. De Iuliis, "Origins and consequences of DNA damage in male germ cells" Reproductive BioMedicine Online, vol. 14, no. 6, pp. 727-733, 2007.
37. A. V. S. K. Rao and C. Shaha, "Role of glutathione S-transferases in oxidative stress-induced male germ cell apoptosis" Free Radical BiologyandMedicine, vol. 29,no. 10,pp. 1015-1027, 2000.
38. X. Jiang, Y. Bai, Z. Zhang, Y. Xin, and L. Cai, "Protection by sulforaphane from type 1 diabetes-induced testicular apoptosis is associated with the up-regulation of Nrf2 expression and function" Toxicology and Applied Pharmacology, vol. 279, no. 2, pp. 198-210, 2014.
39. Y. Wang, Z. Zhang, W. Guo et al., "Sulforaphane reduction of testicular apoptotic cell death in diabetic mice is associated with the upregulation of Nrf2 expression and function" The American Journal of Physiology: Endocrinology andMetabolism, vol. 307, no. 1, pp. E14-E23, 2014.
40. S. James, R. Gallagher, J. Dunbabin, and L. Perry, "Prevalence of vascular complications and factors predictive of their development in young adults with type 1 diabetes: systematic literature review" BMC Research Notes, vol. 7, no. 1, article 593, 2014.
41. D. Deng, T. Evans, K. Mukherjee, D. Downey, and S. Chakrabarti, "Diabetes-induced vascular dysfunction in the retina: role of endothelins" Diabetologia, vol. 42, no. 10, pp. 1228-1234, 1999.
42. S. Fulda,A.M.Gorman, O. Hori, andA. Samali, "Cellular stress responses: cell survival and cell death" International Journal of Cell Biology, vol. 2010, Article ID 214074, 23 pages, 2010.
43. J. E. Tooke and K. L. Goh, "Vascular function in Type 2 diabetes mellitus and pre-diabetes: the case for intrinsic endotheliopathy" Diabetic Medicine, vol. 16, no. 9, pp. 710-715, 1999.
44. H. Tang, Y. P. Tang, N. G. Li et al., "Neuroprotective effects of scutellarin and scutellarein on repeatedly cerebral ischemiareperfusion in rats" Pharmacology Biochemistry and Behavior, vol. 118, pp. 51-59, 2014.
45. G. H. Zhang, Q. Wang, J. J. Chen, X. M. Zhang, S. C. Tam, and Y. T. Zheng, "The anti-HIV-1 effect of scutellarin" Biochemical and Biophysical Research Communications, vol. 334, no. 3, pp. 812-816, 2005.
46. H. Guo, L.-M. Hu, S.-X. Wang et al., "Neuroprotective effects of scutellarin against hypoxic-ischemic-induced cerebral injury via augmentation of antioxidant defense capacity" Chinese Journal of Physiology, vol. 54, no. 6, pp. 399-405, 2011.
47. F. Xiong, C. Xiong, J. Yao, X. Chen, and N. Gu, "Preparation, characterization and evaluation of breviscapine lipid emulsions coated with monooleate-PEG-COOH" International Journal of Pharmaceutics, vol. 421, no. 2, pp. 275-282, 2011.
48. Y. F. Li, Z. H. Gong,M.Yang, Y. M. Zhao, and Z. P. Luo, "Inhibition of the oligosaccharides extracted from Morinda officinalis, a Chinese traditional herbal medicine, on the corticosterone induced apoptosis in PC12 cells" Life Sciences, vol. 72, no. 8, pp. 933-942, 2003.
49. Z. Zheng, H. Chen, G. Ke et al., "Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway" Diabetes, vol. 58, no. 4, pp. 954-964, 2009.